0 XP   0   0   0

Aequus Pharmaceuticals Inc
Buy, Hold or Sell?

Should you buy, hold or sell Aequus Pharmaceuticals Inc?

I guess you are interested in Aequus Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Aequus Pharmaceuticals Inc

Let's start. I'm going to help you getting a better view of Aequus Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Aequus Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Aequus Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Aequus Pharmaceuticals Inc. The closing price on 2023-01-31 was C$0.04 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Aequus Pharmaceuticals Inc Daily Candlestick Chart
Aequus Pharmaceuticals Inc Daily Candlestick Chart
Summary









1. Valuation of Aequus Pharmaceuticals Inc




Current price per share

C$0.04

2. Growth of Aequus Pharmaceuticals Inc




Is Aequus Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$271.8k$1.3m-$872k-190.3%

How much money is Aequus Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$470.2k-$307.8k-$162.4k-34.5%
Net Profit Margin-177.0%-68.2%--

How much money comes from the company's main activities?

3. Financial Health of Aequus Pharmaceuticals Inc




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#630 / 705

Most Revenue
#620 / 705

Most Profit
#388 / 705

Most Efficient
#585 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Aequus Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aequus Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -143.8% means that $-1.44 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -143.8%. The company is making a huge loss. -2
  • The TTM is -177.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-143.8%TTM-177.0%+33.2%
TTM-177.0%YOY-68.2%-108.8%
TTM-177.0%5Y-145.1%-31.9%
5Y-145.1%10Y-206.7%+61.6%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-143.8%0.4%-144.2%
TTM-177.0%0.3%-177.3%
YOY-68.2%0.2%-68.4%
5Y-145.1%-0.7%-144.4%
10Y-206.7%-0.1%-206.6%
1.1.2. Return on Assets

Shows how efficient Aequus Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -18.7% Return on Assets means that Aequus Pharmaceuticals Inc generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -18.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.7%TTM-20.5%+1.8%
TTM-20.5%YOY-9.3%-11.2%
TTM-20.5%5Y-23.5%+3.0%
5Y-23.5%10Y-24.9%+1.5%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.7%0.1%-18.8%
TTM-20.5%0.1%-20.6%
YOY-9.3%-0.1%-9.2%
5Y-23.5%-0.2%-23.3%
10Y-24.9%0.1%-25.0%
1.1.3. Return on Equity

Shows how efficient Aequus Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.0% Return on Equity means Aequus Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-172.3%+172.3%
TTM-172.3%YOY-24.4%-147.9%
TTM-172.3%5Y-76.4%-95.8%
5Y-76.4%10Y-71.0%-5.4%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-0.6%
TTM-172.3%0.4%-172.7%
YOY-24.4%0.4%-24.8%
5Y-76.4%-0.3%-76.1%
10Y-71.0%0.1%-71.1%

1.2. Operating Efficiency of Aequus Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aequus Pharmaceuticals Inc is operating .

  • Measures how much profit Aequus Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -151.3% means the company generated $-1.51  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -151.3%. The company is operating very inefficient. -2
  • The TTM is -172.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-151.3%TTM-172.6%+21.3%
TTM-172.6%YOY-59.8%-112.8%
TTM-172.6%5Y-131.4%-41.2%
5Y-131.4%10Y-198.3%+66.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-151.3%2.5%-153.8%
TTM-172.6%1.6%-174.2%
YOY-59.8%2.7%-62.5%
5Y-131.4%1.8%-133.2%
10Y-198.3%0.8%-199.1%
1.2.2. Operating Ratio

Measures how efficient Aequus Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 2.58 means that the operating costs are $2.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 2.581. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.680. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.581TTM2.680-0.099
TTM2.680YOY1.553+1.127
TTM2.6805Y2.275+0.404
5Y2.27510Y2.426-0.150
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5811.473+1.108
TTM2.6801.456+1.224
YOY1.5531.398+0.155
5Y2.2751.374+0.901
10Y2.4261.191+1.235

1.3. Liquidity of Aequus Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 0.54 means the company has $0.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.544. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.969. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.544TTM0.969-0.426
TTM0.969YOY6.761-5.792
TTM0.9695Y3.347-2.378
5Y3.34710Y3.459-0.112
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5441.880-1.336
TTM0.9691.901-0.932
YOY6.7612.112+4.649
5Y3.3472.182+1.165
10Y3.4591.891+1.568
1.3.2. Quick Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.12 means the company can pay off $0.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.117. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.181. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.181-0.065
TTM0.181YOY1.175-0.994
TTM0.1815Y0.924-0.742
5Y0.92410Y0.829+0.094
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.733-0.616
TTM0.1810.796-0.615
YOY1.1750.808+0.367
5Y0.9240.834+0.090
10Y0.8290.821+0.008

1.4. Solvency of Aequus Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aequus Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aequus Pharmaceuticals Inc to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.14 means that Aequus Pharmaceuticals Inc assets are financed with 113.6% credit (debt) and the remaining percentage (100% - 113.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 1.136. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.855. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.136TTM0.855+0.281
TTM0.855YOY0.602+0.253
TTM0.8555Y0.760+0.096
5Y0.76010Y0.668+0.092
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1360.437+0.699
TTM0.8550.424+0.431
YOY0.6020.398+0.204
5Y0.7600.398+0.362
10Y0.6680.401+0.267
1.4.2. Debt to Equity Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.611-5.611
TTM5.611YOY1.967+3.644
TTM5.6115Y2.665+2.946
5Y2.66510Y2.269+0.396
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.652-0.652
TTM5.6110.675+4.936
YOY1.9670.623+1.344
5Y2.6650.684+1.981
10Y2.2690.697+1.572

2. Market Valuation of Aequus Pharmaceuticals Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aequus Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -11.93 means the investor is paying $-11.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aequus Pharmaceuticals Inc:

  • The EOD is -10.601. Company is losing money. -2
  • The MRQ is -11.926. Company is losing money. -2
  • The TTM is -20.529. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-10.601MRQ-11.926+1.325
MRQ-11.926TTM-20.529+8.603
TTM-20.529YOY-53.997+33.467
TTM-20.5295Y-38.926+18.397
5Y-38.92610Y-38.061-0.864
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-10.601-0.124-10.477
MRQ-11.926-0.437-11.489
TTM-20.529-0.102-20.427
YOY-53.99715.340-69.337
5Y-38.9267.916-46.842
10Y-38.0617.700-45.761
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Aequus Pharmaceuticals Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -8.822. Very Bad. -2
  • The TTM is -11.389. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-8.822TTM-11.389+2.567
TTM-11.389YOY-26.962+15.573
TTM-11.3895Y-31.712+20.323
5Y-31.71210Y-33.510+1.798
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8220.012-8.834
TTM-11.3890.010-11.399
YOY-26.9620.004-26.966
5Y-31.7120.010-31.722
10Y-33.5100.021-33.531

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aequus Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of -16.41 means the investor is paying $-16.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aequus Pharmaceuticals Inc:

  • The EOD is -14.584. Bad. Book ratio is negative. -2
  • The MRQ is -16.407. Bad. Book ratio is negative. -2
  • The TTM is 18.080. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD-14.584MRQ-16.407+1.823
MRQ-16.407TTM18.080-34.487
TTM18.080YOY13.906+4.174
TTM18.0805Y17.277+0.803
5Y17.27710Y16.903+0.375
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-14.5841.415-15.999
MRQ-16.4071.586-17.993
TTM18.0802.019+16.061
YOY13.9062.230+11.676
5Y17.2771.895+15.382
10Y16.9031.505+15.398
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aequus Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.005+23%0.003-237%-0.001-68%0.000-97%
Book Value Growth---2.676-0.292-89%1.625-265%0.547-589%0.721-471%
Book Value Per Share---0.0030.005-159%0.013-120%0.007-140%0.009-130%
Book Value Per Share Growth---2.676-0.292-89%1.625-265%0.547-589%0.721-471%
Current Ratio--0.5440.969-44%6.761-92%3.347-84%3.459-84%
Debt To Asset Ratio--1.1360.855+33%0.602+89%0.760+50%0.668+70%
Debt To Equity Ratio---5.611-100%1.967-100%2.665-100%2.269-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.005+26%-0.003-18%-0.004+16%-0.005+28%
Eps Growth--1.3520.713+90%0.504+168%0.873+55%0.874+55%
Free Cash Flow Per Share---0.004-0.004-11%-0.003-37%-0.003-22%-0.004-9%
Free Cash Flow Per Share Growth--1.367-0.577+142%-1.483+208%-0.890+165%-0.697+151%
Free Cash Flow To Equity Per Share---0.004-0.004-10%0.002-319%0.000-1029%0.000-1309%
Free Cash Flow To Equity Per Share Growth--1.357-0.178+113%0.916+48%29.229-95%25.721-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.577--------
Intrinsic Value_10Y_min---0.114--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.014--------
Intrinsic Value_3Y_max--0.044--------
Intrinsic Value_3Y_min---0.040--------
Intrinsic Value_5Y_max--0.142--------
Intrinsic Value_5Y_min---0.064--------
Net Profit Margin---1.438-1.770+23%-0.682-53%-1.451+1%-2.067+44%
Operating Margin---1.513-1.726+14%-0.598-60%-1.314-13%-1.983+31%
Operating Ratio--2.5812.680-4%1.553+66%2.275+13%2.426+6%
Pb Ratio-14.584+11%-16.40718.080-191%13.906-218%17.277-195%16.903-197%
Pe Ratio-10.601+11%-11.926-20.529+72%-53.997+353%-38.926+226%-38.061+219%
Peg Ratio---8.822-11.389+29%-26.962+206%-31.712+259%-33.510+280%
Price Per Share0.040-13%0.0450.078-42%0.143-68%0.146-69%0.160-72%
Price To Total Gains Ratio-10.617+11%-11.944-21.718+82%-65.037+445%-41.840+250%-1.297-89%
Profit Growth--1.3520.713+90%0.504+168%0.873+55%0.874+55%
Quick Ratio--0.1170.181-36%1.175-90%0.924-87%0.829-86%
Return On Assets---0.187-0.205+9%-0.093-50%-0.235+25%-0.249+33%
Return On Equity----1.7230%-0.2440%-0.7640%-0.7100%
Revenue Growth--1.0040.927+8%1.093-8%1.059-5%1.108-9%
Total Gains Per Share---0.004-0.005+23%0.003-237%-0.001-68%0.000-97%
Total Gains Per Share Growth--1.3390.654+105%6.577-80%2.710-51%1.426-6%
Usd Book Value---271895.899458349.029-159%1330426.560-120%675708.719-140%908777.892-130%
Usd Book Value Change Per Share---0.003-0.003+23%0.002-237%-0.001-68%0.000-97%
Usd Book Value Per Share---0.0020.003-159%0.010-120%0.005-140%0.007-130%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.004+26%-0.002-18%-0.003+16%-0.004+28%
Usd Free Cash Flow---402862.801-358427.442-11%-255239.155-37%-130782.518-68%-108985.432-73%
Usd Free Cash Flow Per Share---0.003-0.003-11%-0.002-37%-0.002-22%-0.003-9%
Usd Free Cash Flow To Equity Per Share---0.003-0.003-10%0.001-319%0.000-1029%0.000-1309%
Usd Price Per Share0.030-13%0.0340.058-42%0.107-68%0.109-69%0.120-72%
Usd Profit---374052.025-470268.564+26%-307856.115-18%-433306.421+16%-479557.594+28%
Usd Revenue--260037.650346797.711-25%505720.736-49%363066.516-28%327897.397-21%
Usd Total Gains Per Share---0.003-0.003+23%0.002-237%-0.001-68%0.000-97%
 EOD+2 -3MRQTTM+21 -17YOY+8 -305Y+12 -2610Y+12 -26

3.2. Fundamental Score

Let's check the fundamental score of Aequus Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.601
Price to Book Ratio (EOD)Between0-1-14.584
Net Profit Margin (MRQ)Greater than0-1.438
Operating Margin (MRQ)Greater than0-1.513
Quick Ratio (MRQ)Greater than10.117
Current Ratio (MRQ)Greater than10.544
Debt to Asset Ratio (MRQ)Less than11.136
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.187
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Aequus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.045
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-09-302021-12-312022-03-312022-06-302022-09-30
Total Stockholder Equity 2,089-3001,789-897892-756136-500-364
Net Tangible Assets  2,044-2551,789-897892-756136-500-364



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets2,673
Total Liabilities3,037
Total Stockholder Equity-364
 As reported
Total Liabilities 3,037
Total Stockholder Equity+ -364
Total Assets = 2,673

Assets

Total Assets2,673
Total Current Assets1,282
Long-term Assets1,282
Total Current Assets
Cash And Cash Equivalents 764
Net Receivables 275
Inventory 130
Total Current Assets  (as reported)1,282
Total Current Assets  (calculated)1,169
+/- 113
Long-term Assets
Property Plant Equipment 824
Other Assets 567
Long-term Assets  (as reported)1,390
Long-term Assets  (calculated)1,390
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,359
Long-term Liabilities678
Total Stockholder Equity-364
Total Current Liabilities
Short Long Term Debt 2,000
Accounts payable 117
Other Current Liabilities 2,000
Total Current Liabilities  (as reported)2,359
Total Current Liabilities  (calculated)4,117
+/- 1,758
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt803
Long-term Liabilities  (as reported)678
Long-term Liabilities  (calculated)803
+/- 125
Total Stockholder Equity
Common Stock23,991
Retained Earnings -28,699
Other Stockholders Equity 4,344
Total Stockholder Equity (as reported)-364
Total Stockholder Equity (calculated)-364
+/-0
Other
Capital Stock23,991
Common Stock Shares Outstanding 132,634
Net Debt 1,265
Net Invested Capital 1,665
Net Tangible Assets -364
Net Working Capital -1,076



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
1,499
4,154
4,547
3,352
2,672
2,252
1,863
2,784
1,997
1,959
3,143
2,623
1,673
1,478
1,340
3,702
3,135
4,481
4,835
4,609
4,348
3,546
2,588
2,673
2,6732,5883,5464,3484,6094,8354,4813,1353,7021,3401,4781,6732,6233,1431,9591,9972,7841,8632,2522,6723,3524,5474,1541,499
   > Total Current Assets 
599
3,298
3,476
2,340
1,715
1,350
1,011
1,975
1,235
686
1,947
1,504
1,108
987
923
3,303
2,768
4,112
4,491
3,779
3,593
2,826
1,880
1,282
1,2821,8802,8263,5933,7794,4914,1122,7683,3039239871,1081,5041,9476861,2351,9751,0111,3501,7152,3403,4763,298599
       Cash And Cash Equivalents 
353
3,044
3,091
1,860
1,165
842
451
983
370
405
1,457
1,049
485
329
325
2,338
1,719
3,337
3,628
2,886
2,392
2,238
1,386
764
7641,3862,2382,3922,8863,6283,3371,7192,3383253294851,0491,4574053709834518421,1651,8603,0913,044353
       Net Receivables 
142
166
212
329
430
399
422
851
731
204
433
396
556
598
551
630
780
485
635
672
941
266
297
275
275297266941672635485780630551598556396433204731851422399430329212166142
       Other Current Assets 
105
88
133
120
96
84
0
0
43
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004300849612013388105
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
1,273
1,196
1,118
565
491
417
399
366
369
344
830
755
720
708
1,390
1,3907087207558303443693663994174915651,1181,1961,273000000000
       Property Plant Equipment 
34
36
44
39
7
6
11
16
14
571
540
509
480
449
417
399
366
334
304
274
242
211
179
824
8241792112422743043343663994174494805095405711416116739443634
       Intangible Assets 
800
772
988
945
931
885
839
793
747
701
649
606
85
42
0
0
0
35
40
45
0
0
0
0
00004540350004285606649701747793839885931945988772800
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
1,273
1,196
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,1961,273000000000
> Total Liabilities 
555
493
848
556
367
397
570
540
315
935
2,328
2,437
2,550
2,717
2,751
3,069
2,561
2,451
2,408
2,519
2,559
2,654
2,452
3,037
3,0372,4522,6542,5592,5192,4082,4512,5613,0692,7512,7172,5502,4372,328935315540570397367556848493555
   > Total Current Liabilities 
555
493
848
556
367
397
570
540
315
509
445
544
476
576
491
789
384
509
441
2,386
2,457
2,585
2,416
2,359
2,3592,4162,5852,4572,386441509384789491576476544445509315540570397367556848493555
       Short-term Debt 
0
0
0
0
0
0
0
0
0
96
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000096000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
96
0
0
0
0
0
0
0
0
0
1,869
1,927
1,986
2,000
2,000
2,0002,0001,9861,9271,86900000000096000000000
       Accounts payable 
555
493
747
397
330
367
533
505
269
338
245
251
250
330
308
503
161
235
230
180
157
278
96
117
11796278157180230235161503308330250251245338269505533367330397747493555
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,0002,0000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
427
1,883
1,893
2,074
2,141
2,260
2,281
2,176
1,941
1,967
133
102
69
36
678
67836691021331,9671,9412,1762,2812,2602,1412,0741,8931,883427000000000
> Total Stockholder Equity
944
3,662
3,699
2,796
2,305
1,855
1,293
2,244
1,682
1,024
815
186
-877
-1,239
-1,411
632
574
2,030
2,427
2,089
1,789
892
136
-364
-3641368921,7892,0892,4272,030574632-1,411-1,239-8771868151,0241,6822,2441,2931,8552,3052,7963,6993,662944
   Common Stock
9,401
12,873
17,088
17,095
17,095
17,399
17,443
18,943
18,935
18,935
19,131
19,118
19,083
19,083
19,065
21,173
21,172
23,166
23,991
23,991
23,991
23,991
23,991
23,991
23,99123,99123,99123,99123,99123,99123,16621,17221,17319,06519,08319,08319,11819,13118,93518,93518,94317,44317,39917,09517,09517,08812,8739,401
   Retained Earnings -28,699-28,198-27,426-26,509-26,182-25,801-25,322-24,700-24,535-24,283-24,060-23,655-22,617-21,957-21,279-20,550-19,881-19,229-18,563-17,746-17,106-16,155-11,155-10,338
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
3,080
3,182
0
0
0
0
0
0
0
0
0
4,186
4,236
4,280
4,308
4,327
4,343
4,344
4,3444,3434,3274,3084,2804,2364,1860000000003,1823,080000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue2,715
Cost of Revenue-26
Gross Profit2,6892,689
 
Operating Income (+$)
Gross Profit2,689
Operating Expense-4,082
Operating Income-1,367-1,393
 
Operating Expense (+$)
Research Development297
Selling General Administrative3,631
Selling And Marketing Expenses-
Operating Expense4,0823,928
 
Net Interest Income (+$)
Interest Income13
Interest Expense-455
Net Interest Income-442-442
 
Pretax Income (+$)
Operating Income-1,367
Net Interest Income-442
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,810-1,367
EBIT - interestExpense = -2,062
-1,810
-1,355
Interest Expense455
Earnings Before Interest and Taxes (ebit)-1,608-1,355
Earnings Before Interest and Taxes (ebitda)-1,227
 
After tax Income (+$)
Income Before Tax-1,810
Tax Provision--
Net Income From Continuing Ops-1,810-1,810
Net Income-1,810
Net Income Applicable To Common Shares-1,810
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net0442
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
BLG.AU
1 minute ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of BLG.AU.

BLG.AU Daily Candlestick Chart
BAS.AU
3 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of BAS.AU.

BAS.AU Daily Candlestick Chart
ATA.AU
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ATA.AU.

ATA.AU Daily Candlestick Chart
ARR.AU
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ARR.AU.

ARR.AU Daily Candlestick Chart
ARG.AU
7 minutes ago

I found you a Golden Cross on the daily chart of ARG.AU.

ARG.AU Daily Candlestick Chart
AQC.AU
7 minutes ago

I found you a Death Cross on the daily chart of AQC.AU.

AQC.AU Daily Candlestick Chart
AMX.AU
8 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of AMX.AU.

AMX.AU Daily Candlestick Chart
AKP.AU
10 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AKP.AU.

AKP.AU Daily Candlestick Chart
ADH.AU
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADH.AU.

ADH.AU Daily Candlestick Chart
ABP.AU
13 minutes ago

I found you a Golden Cross on the daily chart of ABP.AU.

ABP.AU Daily Candlestick Chart
WAM.AU
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WAM.AU.

WAM.AU Daily Candlestick Chart
VR8.AU
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VR8.AU.

VR8.AU Daily Candlestick Chart
VGE.AU
23 minutes ago

I found you a Golden Cross on the daily chart of VGE.AU.

VGE.AU Daily Candlestick Chart
SVY.AU
45 minutes ago

I found you a Golden Cross on the daily chart of SVY.AU.

SVY.AU Daily Candlestick Chart
SPT.AU
49 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of SPT.AU.

SPT.AU Daily Candlestick Chart
SMP.AU
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SMP.AU.

SMP.AU Daily Candlestick Chart
SGP.AU
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGP.AU.

SGP.AU Daily Candlestick Chart
SDR.AU
59 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SDR.AU.

SDR.AU Daily Candlestick Chart
RMS.AU
1 hour ago

I found you a Golden Cross on the daily chart of RMS.AU.

RMS.AU Daily Candlestick Chart
PLL.AU
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PLL.AU.

PLL.AU Daily Candlestick Chart
PGD.AU
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PGD.AU.

PGD.AU Daily Candlestick Chart
OML.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OML.AU.

OML.AU Daily Candlestick Chart